Global Bone Metastasis Market report examines the market position and viewpoint of the market globally, from various angles, such as key players, geological regions, types of diagnosis and treatment. And also cover the other information such as Bone Metastasis Market trends, Top players, chapter-wise Description followed by various user perceptions and Forecast till 2023.
Global Bone Metastasis Market – Overview
Bone metastasis is characterized by the spreading of cancerous cells from their original site to a bone. All types of cancer can show bone-metastasis. However, it is estimated that breast cancer and prostate cancer are commonly associated with the disease. The medical condition is frequent for spine, pelvis, and thighs. Urinary incontinence, bowel incontinence, and hypercalcemia are some of the common symptoms of the disease. The increasing prevalence of bone metastasis is expected to be a major driver for the market growth during the forecast period. According to a study published in the Oncology Reviews Journal in 2017, the relative occurrence of bone metastasis was estimated to be around 65 to 75% for both breast and prostate cancers suffering patients, respectively. Moreover, the growing geriatric population, increasing healthcare expenditures, and increasing R&D in the market are estimated to drive the market growth during the forecast period. According to the American Society of Clinical Oncology in 2016, approximately 60% of the total cancer patients aged 65 years or more. However, factors such as lack of healthcare services in low-income countries, the high cost of treatment, and related side effects are estimated to restrain the market growth during the forecast period. According to a study published in the Journal of Spine Surgery in 2017, the mean total cost of therapeutic modalities such as vertebroplasty was estimated to be about USD 14,114 in 2014. The global bone metastasis market is expected to grow at an approximate CAGR of 8.4% during the forecast period
Get Exclusive Sample Copy of Bone Metastasis Market @ https://www.marketresearchfuture.com/sample_request/5776
Bone Metastasis Market – Leading players
- Hoffmann-La Roche Ltd (Switzerland)
- Bayer AG (Germany)
- Merck & Co., Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Novartis AG (Switzerland)
- Pharmalucence Inc. (England)
- Koninklijke Philips N.V. (the Netherlands)
- GENERAL ELECTRIC (U.S.)
- Siemens AG (Germany)
- TOSHIBA CORPORATION (Japan), and others.
Global Bone Metastasis Market – Regional Analysis
America dominates the global bone metastasis market owing to the presence of a well-developed healthcare sector, increasing prevalence of breast cancer, and rising healthcare sector within the region. Europe stands second in the market and is followed by Asia Pacific owing to the availability of funds for research and a huge patient population. Europe is segmented into Western Europe and Eastern Europe. Western Europe leads the regional market due to the presence of developed economies such as Italy, Germany, France, and others within the region. Asia Pacific is projected to be the fastest growing region in the global bone metastasis market. The presence of a developing healthcare sector and increasing prevalence of cancer are expected to be the major drivers for the market growth during the forecast period. The Middle East and Africa holds the least share in the market. This can be attributed to the presence of poor economies, stringent government policies, and lack of healthcare services, especially within the African region.
Global Bone Metastasis – Market Segmentation
The global bone metastasis market is segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis of type, the market is segmented into osteolytic bone metastasis, osteoblastic bone metastasis, mixed bone metastasis, and others. On the basis of diagnosis, the market is categorized into biopsy, blood test, imaging, and others. The imaging segment is sub-segmented into X-ray, bone scintigraphy, computerized tomography, magnetic resonance imaging, positron emission tomography, and others. On the basis of treatment, the market is segmented into medical therapies, surgery, medication, and others. The medical therapies segment is sub-segmented into chemotherapy, targeted therapy, hormone therapy, ablation therapy, and others. The surgery segment is sub-segmented into vertebroplasty, kyphoplasty, and others. The medication segment is sub-segmented into pain medications, bone building medications, and others. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, pharmacies, and ambulatory surgical centers.
Get Amazing Discount on Report @ https://www.marketresearchfuture.com/check-discount/5776
TOC of Bone Metastasis Market Research Report – Global Forecast to 2023
- Report Prologue
- Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
- Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
- Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Threats
4.5 Macroeconomic Indicators
TOC CONTINUED…
Ask any Queries to Experts about Niche Segments, Requires Regional Data and Top Players @ https://www.marketresearchfuture.com/enquiry/5776
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Your information will never be shared with any third party.